Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects
Abstract
Share and Cite
Gangwar, S.K.; Kumar, A.; Yap, K.C.-H.; Jose, S.; Parama, D.; Sethi, G.; Kumar, A.P.; Kunnumakkara, A.B. Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals 2022, 15, 624. https://doi.org/10.3390/ph15050624
Gangwar SK, Kumar A, Yap KC-H, Jose S, Parama D, Sethi G, Kumar AP, Kunnumakkara AB. Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals. 2022; 15(5):624. https://doi.org/10.3390/ph15050624
Chicago/Turabian StyleGangwar, Shailendra Kumar, Aviral Kumar, Kenneth Chun-Hong Yap, Sandra Jose, Dey Parama, Gautam Sethi, Alan Prem Kumar, and Ajaikumar B. Kunnumakkara. 2022. "Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects" Pharmaceuticals 15, no. 5: 624. https://doi.org/10.3390/ph15050624
APA StyleGangwar, S. K., Kumar, A., Yap, K. C.-H., Jose, S., Parama, D., Sethi, G., Kumar, A. P., & Kunnumakkara, A. B. (2022). Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals, 15(5), 624. https://doi.org/10.3390/ph15050624